KZR – kezar life sciences, inc. (US:NASDAQ)
Stock Stats
News
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
Kezar Life Sciences (NASDAQ:KZR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Kezar Life Sciences (NASDAQ:KZR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form SCHEDULE 13G/A Kezar Life Sciences, Filed by: Stonepine Capital Management, LLC
Form SCHEDULE 13G/A Kezar Life Sciences, Filed by: BML Investment Partners, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.